-
Survivor Profile
Touched by an AngelJonny Imerman is the heart and hub of a network of cancer survivors.
by Pamela Ferdinand
-
Yesterday & Today
A Leading LadyBetty Ford's candor about her breast cancer diagnosis helped bring a private issue out of the shadows.
by Corinna Wu
-
Teaming Up for Better Treatment
Across the country, survivors' opinions and actions are influencing cancer care.
by Stephen Ornes
-
Get Involved
Driving the Road to RecoveryA cancer caregiver volunteers by driving patients to treatment.
by Yvonne Lee
-
Forward Look
India Overrides Patent on Cancer DrugWill it face a backlash for its response to Nexavar's high price?
by Corinna Wu
-
Forward Look
The Dense Breast DebateSome states are mandating that doctors tell patients about breast density, which can affect cancer risk.
by Mitzi Baker
-
Survivor Profile
Spreading the WordAn African-American banking pioneer finds fulfillment in increasing prostate cancer awareness.
by Yvonne Lee
-
Forward Look
The Value of Bone MarrowA court rules in favor of compensating some stem cell donors.
by Karen Patterson
-
First Person
Circle of SupportDespite the foreign terrain, family, friends and faith help a cancer patient find familiarity and comfort.
by Cynthia Ryan
Cancer Talk
Treating Smoldering Multiple Myeloma
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona